1. Lengrand, Justine, Pastushenko, Ievgenia, Vanuytven, Sebastiaan, Bernet, Agnès, Blanpain, Cédric. 2023. Pharmacological targeting of netrin-1 inhibits EMT in cancer. In Nature, 620, 402-408. doi:10.1038/s41586-023-06372-2. https://pubmed.ncbi.nlm.nih.gov/37532929/
2. Wang, Kankai, Pan, Sishi, Zhao, Peiqi, Zhuge, Qichuan, Yang, Jianjing. 2022. PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor. In Theranostics, 12, 3847-3861. doi:10.7150/thno.71100. https://pubmed.ncbi.nlm.nih.gov/35664063/
3. Pradella, Davide, Deflorian, Gianluca, Pezzotta, Alex, Mehlen, Patrick, Ghigna, Claudia. 2021. A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis. In Nature communications, 12, 4872. doi:10.1038/s41467-021-24998-6. https://pubmed.ncbi.nlm.nih.gov/34381052/
4. Furtado, Jessica, Geraldo, Luiz Henrique, Leser, Felipe Saceanu, Eichmann, Anne, Boyé, Kevin. 2023. Netrin-1 binding to Unc5B regulates Blood-Retina Barrier integrity. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.01.21.525006. https://pubmed.ncbi.nlm.nih.gov/36711611/
5. Pan, Ruilin, Zhang, Yiming, Cheng, Yanmei, Feng, Shanshan, Zheng, Xiaofei. 2024. Identification of UNC5B as a novel aggressive biomarker for osteosarcoma based on basement membrane genes. In Gene, 930, 148871. doi:10.1016/j.gene.2024.148871. https://pubmed.ncbi.nlm.nih.gov/39154972/
6. Tan, S-F, Ni, J-X, Xiong, H. . LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9. In European review for medical and pharmacological sciences, 24, 2271-2280. doi:10.26355/eurrev_202003_20493. https://pubmed.ncbi.nlm.nih.gov/32196578/